• About
  • Blog
  1. Home
  2. Blog
  3. Companies
  4. CNMD

CONMED Corporation(CNMD)

New York Stock Exchange
Sector: Healthcare | Industry: Medical - Devices
CONMED Corporation logo

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Latest News & Analysis

CONMED Corporation Q4 2024 Earnings Analysis: Insights into CNMD's Performance and Outlook, stock analysis.
Feb 21, 2025

CONMED Q4 2024: Weak Outlook Clouds Earnings Beat, Analyst Concerns Mount

CONMED (CNMD) faces investor concerns despite Q4 earnings beat. A weak outlook and analyst downgrades raise questions about future performance.

Read more →
CONMED (CNMD) Q4 2024 Earnings Analysis: Stock performance, revenue growth, and factors influencing cautious outlook.
Feb 21, 2025

CONMED Q4 2024 Earnings: Weak Outlook Concerns Investors

CONMED (CNMD) faces investor concerns despite Q4 earnings beat due to a weak outlook. Analysis of market reaction, competitive pressures, and strategic responses.

Read more →

Professional-grade financial analysis tools for informed investment decisions.

Product

  • Features
  • Pricing

Resources

  • Blog
  • Knowledge Base
  • Community
  • Market Data

Company

  • About
  • Careers
  • Contact
  • Partners

Legal

  • Privacy
  • Terms
  • License
  • Security

© 2025 Monexa. All rights reserved. Market data provided by financial exchanges and may be delayed as specified by financial exchanges or our data providers.